Lisberg Lends Insight About the TROPION-Lung01 Trial of Dato-DXd in NSCLC

Season 10 Episode 48  ·  Aug 01, 2024, 06:00 PM

Headliner
Share
Subscribe

Dr Lisberg discusses key findings from the TROPION-Lung01 trial of Dato-DXd in patients with previously treated advanced or metastatic NSCLC.

Share
Subscribe
Next
Halmos on the AE Profiles of Dato-DXd and Other ADCs in NSCLC
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air